Over 115 companies located in various regions across the globe claim to provide contract fill / finish (Roots Analysis)


Posted April 13, 2021 by steffan987

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols
 
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.

To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

The USD 4.2 billion (by 2030) financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:
 Types of Primary Packaging Containers
 Ampoules
 Cartridges
 Syringes
 Vials

 Types of Biologics
 Peptides / proteins
 Antibodies
 Vaccines
 Cell therapies
 Gene therapies
 Viral products
 Oligonucleotides
 Others

 Company Size
 Small-sized
 Mid-sized
 Large / very large

 Scale of Operation
 Preclinical
 Clinical
 Commercial

 Key Therapeutic Areas
 Cancer
 Infectious diseases
 Autoimmune diseases
 Cardiovascular diseases
 Other indications

 Key Geographical Regions
 North America (US, Canada)
 Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
 Asia-Pacific (Japan, China, South Korea, India and Australia)

The Biologics Fill / Finish Services Market, 2019-2030.” report features the following companies, which we identified to be key players in this domain:
 Advanced BioScience Laboratories (ABL)
 Albany Molecular Research (AMRI)
 Biocon
 BioPharma Solutions
 BioReliance
 Boehringer Ingelheim BioXcellence
 ChemPartner
 Emergent BioSolutions
 IDT Biologika
 Lonza
 LuinaBio
 Mycenax Biotech
 Patheon
 Recipharm
 Vetter Pharma
 WuXi Biologics

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Competitive Landscape

5. Company Competitiveness Analysis

6. Biologics Fill / Finish Service Providers in North America: Company Profiles

7. Biologics Fill / Finish Service Providers in Europe: Company Profiles

8. Biologics Fill / Finish Service Providers in Asia-Pacific: Company Profiles

9. Partnerships and Collaborations

10. Recent Expansions

11. Capacity Analysis

12. Demand Analysis

13. Biologics Manufacturing and Fill / Finish: Key Performance Indicator Analysis

14. Market Sizing and Opportunity Analysis

15. Future Growth Opportunities

16. Case Study: Robotic Systems in Fill / Finish Operations

17. Case Study: Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations

18. Conclusion

19. Interview Transcripts

20. Appendix 1: Tabulated Data

21. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Steffan Joe
Phone 0594623595
Business Address 108 strreet
New York
Country Afghanistan
Categories Biotech , Health , Industry
Tags health , pharma , report
Last Updated April 13, 2021